Machine learning (ML) algorithms are optimized for the distribution represented by the training data. For outlier data, they often deliver predictions with equal confidence, even though these should not be trusted. In order to deploy ML-based digital pathology solutions in clinical practice, effective methods for detecting anomalous data are crucial to avoid incorrect decisions in the outlier scenario. We propose a new unsupervised learning approach for anomaly detection in histopathology data based on generative adversarial networks (GANs). Compared to the existing GAN-based methods that have been used in medical imaging, the proposed approach improves significantly on performance for pathology data. Our results indicate that histopathology imagery is substantially more complex than the data targeted by the previous methods. This complexity requires not only a more advanced GAN architecture but also an appropriate anomaly metric to capture the quality of the reconstructed images.
Equivariant Imaging Biomarkers for Robust Unsupervised Segmentation of Histopathology
Department of Biomedical Engineering, Yale University（生物医学工程系，耶鲁大学）；Department of Radiology & Biomedical Imaging, Yale University（放射科与生物医学成像系，耶鲁大学）；Department of Urology, Yale University（泌尿外科系，耶鲁大学）；Medical Scientist Training Program, Yale University（医学科学家培训计划，耶鲁大学）
University of Sydney（悉尼大学）；University of New South Wales（新南威尔士大学）；Brigham and Women’s Hospital（布莱根妇女医院）；Harvard Medical School（哈佛医学院）；University of Pittsburgh（匹兹堡大学）；Microsoft Corporation（微软公司）
Pathology-Informed Latent Diffusion Model for Anomaly Detection in Lymph Node Metastasis
School of Electrical Engineering, Korea University, Seoul 02841, Korea（韩国大学电子工程学院）；Department of Pathology, Korea University Anam Hospital and Department of Biomedical Informatics, Korea University College of Medicine, Seoul 02841, Korea（韩国大学医学院病理学系）；Department of Hospital Pathology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea（韩国天主大学医学院圣玛丽医院医院病理学系）
